October 26, 2017
A Delaware federal judge has dismissed the fourth version of a False Claims Act kickback suit against Medco Health Solutions Inc., this time with prejudice, saying Thursday that it can't get over the public disclosure bar and any further attempts would be "futile."
June 07, 2017
The New Jersey Supreme Court on Wednesday said the state attorney general's office could not issue subpoenas in False Claims Act cases initiated by whistleblowers after a deadline has passed for the agency to intervene even though there is no explicit time limit on that subpoena power under state law.
July 07, 2016
Pharmacy benefits company Medco Health Solutions Inc. argued Thursday that a former executive suing the company on behalf of the federal government doesn't bring any new information to the False Claims Act case relating to an alleged prescription drug fraud scheme and the suit should be tossed.
March 18, 2016
The New Jersey Superior Court ruled Friday that the state attorney general cannot subpoena two former employees of a pharmacy benefits company that's the target of a False Claims Act suit because the deadline had long passed for the state to intervene in the case.
January 15, 2016
A former Medco Health Solutions Inc. executive has told a Delaware federal court he could bring a False Claims Act suit because he had firsthand knowledge of the company's scheme to defraud government insurance programs by hiding discounts received on AstraZeneca drugs.
November 24, 2015
Medco Health Solutions Inc. asked a Delaware federal judge to throw out a former employee's False Claims Act suit alleging the pharmacy benefit company defrauded state and federal insurance programs by hiding discounts it received on drugs, saying the employee lacks the firsthand knowledge of the discounts necessary to bring the suit.
October 23, 2015
A former Medco Health Solutions Inc. executive is suing the company in Delaware federal court on behalf of the U.S., California, Florida and New Jersey over claims the company defrauded state and federal health insurance programs by accepting undisclosed discounts from drug manufacturers and not passing on the savings to its clients, according to a recently amended complaint.